Outset Medical (OM) Current Deferred Revenue (2019 - 2026)

Outset Medical (OM) has 8 years of Current Deferred Revenue data on file, last reported at $12.6 million in Q1 2026.

• Current Deferred Revenue for Q1 2026 came in at $12.6 million, down 4.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.6 million (down 4.15% YoY), and the FY2025 annual result was $13.8 million, up 8.17% from the prior year.
• Current Deferred Revenue retreated to $12.6 million in Q1 2026 per OM's latest filing, from $13.8 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $14.9 million in Q3 2025 and troughed at $6.8 million in Q1 2022.
• A 5-year average of $11.4 million and a median of $12.6 million in 2026 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2022 and 2026: Current Deferred Revenue surged 93.02% in 2022, then decreased 4.15% in 2026.
• A 5-year view of Current Deferred Revenue shows it stood at $8.7 million in 2022, then soared by 35.38% to $11.7 million in 2023, then advanced by 8.75% to $12.8 million in 2024, then gained by 8.17% to $13.8 million in 2025, then dropped by 8.37% to $12.6 million in 2026.
• Business Quant data shows OM's Current Deferred Revenue at $12.6 million in Q1 2026, $13.8 million in Q4 2025, and $14.9 million in Q3 2025.